These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30886380)

  • 1. The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro.
    Stakheev D; Taborska P; Strizova Z; Podrazil M; Bartunkova J; Smrz D
    Sci Rep; 2019 Mar; 9(1):4761. PubMed ID: 30886380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation.
    Lu W; Tinsley HN; Keeton A; Qu Z; Piazza GA; Li Y
    Eur J Pharmacol; 2009 Jan; 602(1):8-14. PubMed ID: 19026633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
    Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
    Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.
    Wu X; Luo F; Li J; Zhong X; Liu K
    Int J Oncol; 2016 Apr; 48(4):1333-40. PubMed ID: 26820603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury.
    Wang C; Zhu H; Sun Z; Xiang Z; Ge Y; Ni C; Luo Z; Qian W; Han X
    Am J Physiol Cell Physiol; 2014 Aug; 307(3):C234-44. PubMed ID: 24898581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
    Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
    Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
    Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth.
    Ono M; Yin P; Navarro A; Moravek MB; Coon V JS; Druschitz SA; Gottardi CJ; Bulun SE
    Fertil Steril; 2014 May; 101(5):1441-9. PubMed ID: 24534281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
    Rajan P; Sudbery IM; Villasevil ME; Mui E; Fleming J; Davis M; Ahmad I; Edwards J; Sansom OJ; Sims D; Ponting CP; Heger A; McMenemin RM; Pedley ID; Leung HY
    Eur Urol; 2014 Jul; 66(1):32-9. PubMed ID: 24054872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response.
    Jang J; Jung Y; Chae S; Bae T; Kim SM; Shim YJ; Chung SI; Yoon Y
    Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):394-402. PubMed ID: 30466341
    [No Abstract]   [Full Text] [Related]  

  • 14. Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt/β-catenin pathway.
    Zhu M; Yu X; Zheng Z; Huang J; Yang X; Shi H
    Phytother Res; 2020 Apr; 34(4):817-824. PubMed ID: 31782192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
    Lu W; Li Y
    J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells.
    Suebsoonthron J; Jaroonwitchawan T; Yamabhai M; Noisa P
    Anticancer Drugs; 2017 Jun; 28(5):469-479. PubMed ID: 28240680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
    Mashima T; Taneda Y; Jang MK; Mizutani A; Muramatsu Y; Yoshida H; Sato A; Tanaka N; Sugimoto Y; Seimiya H
    Oncotarget; 2017 Jul; 8(29):47902-47915. PubMed ID: 28615517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive microRNA-145 targets catenin δ-1 to regulate Wnt/β-catenin signaling in human colon cancer cells.
    Yamada N; Noguchi S; Mori T; Naoe T; Maruo K; Akao Y
    Cancer Lett; 2013 Jul; 335(2):332-42. PubMed ID: 23499891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.